No Picture
News

ChemDiv Forges Strategic Partnership with The University of Texas Medical Branch (UTMB) to Expand Its High-throughput Screening Research Capabilities

SAN DIEGO, Dec. 28, 2023 /PRNewswire/ — ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the expansion of its inventory and […]

News

Fresh Start Surgical Gifts Celebrates a Year of Compassionate Care, Community Impact and Transformative Milestones, Looking Ahead to 2024

SAN DIEGO, Dec. 27, 2023 /PRNewswire/ — As we bid farewell to another transformative year, national nonprofit Fresh Start Surgical Gifts proudly reflects on its significant accomplishments in 2023. With a steadfast commitment to providing […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Senhwa Biosciences Received Taiwan FDA IND Approval for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

TAIPEI and SAN DIEGO, Dec. 26, 2023 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced today that Taiwan Food and […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Experts Gather at SDSC to Discuss Using Data and AI to Improve Responses to Mass Casualty Events

Computer science and AI researchers, school safety managers, 911 program directors, service providers and policymakers discussed using 911 data streams with advanced AI models to improve response to mass casualty events, especially on school campuses. […]


ADVERTISEMENT — Advertise With Biotech Networks
News

ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics

SAN DIEGO & SINGAPORE–(BUSINESS WIRE)–The collaboration aims to produce off-the-shelf TCR-based bispecific molecules that could lead to more effective treatments for solid tumors. Click here to view original post

News

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced an update on multi-cytokine programs EQ101 in development for […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster

KING OF PRUSSIA, Pa. & SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the publication in Lancet Infectious Diseases of a Phase 3 study showing that […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Centricity Vision Announces CEO Transition: Leonard Borrmann to Succeed Rob Thornhill as Chief Executive Officer

CARLSBAD, Calif., Dec. 20, 2023 /PRNewswire/ — Centricity Vision Inc., a global, commercial-stage ophthalmic technology company, today named Leonard Borrmann as the company’s new Chief Executive Officer (CEO), effective immediately. Borrmann previously served as Centricity’s […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

National University Partners with Jewish Family Service of San Diego to Expand Mobile Healthcare Clinic to Local Underserved Communities

National University announces partnership with Jewish Family Service of San Diego to positively impact healthcare outreach for the San Diego underserved community SAN DIEGO, Dec. 19, 2023 /PRNewswire-PRWeb/ — National University (NU) — a nonprofit […]

News

Biocytogen Enters into Multi-Target Antibody Agreement With Neurocrine Biosciences

BEIJING & SAN DIEGO–(BUSINESS WIRE)– #Biocytogen–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) today announced that it has entered into an antibody evaluation and option agreement with Neurocrine Biosciences, Inc. The agreement grants Neurocrine Biosciences […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity

SAN DIEGO, Dec. 19, 2023 /PRNewswire/ — Abzena, the leading end-to-end CDMO for complex biologics and bioconjugates, has co-authored a publication with the US Food and Drug Administration (FDA) demonstrating the potential of the MHC […]


ADVERTISEMENT — Advertise With Biotech Networks
News

MBrace Therapeutics Announces Initiation of Patient Dosing in Phase 1 Clinical Trial Evaluating Investigational Antibody-Drug Conjugate MBRC-101

SAN DIEGO–(BUSINESS WIRE)–MBrace™ Therapeutics, Inc. (“MBrace”), a clinical-stage biopharmaceutical company devoted to improving the lives of patients with cancer by developing novel antibody-drug conjugates (ADCs), today announced the successful initiation of patient dosing in its […]

News

Lassen Therapeutics Announces Closing of Oversubscribed $85 Million Series B Financing and Announces First Patient Dosed in the Phase 1 Trial Evaluating LASN01 in Thyroid Eye Disease

SAN DIEGO–(BUSINESS WIRE)–Lassen Therapeutics, a clinical stage biotech company developing first-in-class antibody therapeutics, LASN01, targeting interleukin-11 receptor (IL-11R) as a potential treatment for fibro-inflammatory diseases such as TED and IPF, and a highly potent, first-in-class […]